Page last updated: 2024-08-25

clarithromycin and Familial Waldenstrom's Macroglobulinaemia

clarithromycin has been researched along with Familial Waldenstrom's Macroglobulinaemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coleman, M; Leonard, J; Lyons, L; Michaeli, J; Nahum, K; Niesvizky, R; Pearse, R; Pekle, K	1
Anagnostopoulos, N; Dimopoulos, MA; Economopoulos, T; Hamilos, G; Margaritis, D; Matsouka, C; Panayiotidis, P; Tsatalas, C; Zomas, A	1
Coleman, M; Leonard, J; Lyons, L; Niesvizky, R; Szelenyi, H	1
Käser, L; Naumann, UK; Steurer-Stey, C; Vetter, W	1

Reviews

1 review(s) available for clarithromycin and Familial Waldenstrom's Macroglobulinaemia

Article	Year
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone. Seminars in oncology, 2003, Volume: 30, Issue:2 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Clinical Trials, Phase II as Topic; Dexamethasone; Humans; Thalidomide; Waldenstrom Macroglobulinemia	2003

Trials

1 trial(s) available for clarithromycin and Familial Waldenstrom's Macroglobulinaemia

Article	Year
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone. Seminars in oncology, 2003, Volume: 30, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Follow-Up Studies; Humans; Middle Aged; Omeprazole; Thalidomide; Treatment Outcome; Waldenstrom Macroglobulinemia	2003

Other Studies

2 other study(ies) available for clarithromycin and Familial Waldenstrom's Macroglobulinaemia

Article	Year
BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia. Leukemia & lymphoma, 2002, Volume: 43, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Disease Progression; Female; Humans; Immunoglobulins; Male; Middle Aged; Multiple Myeloma; Thalidomide; Time Factors; Treatment Outcome; Waldenstrom Macroglobulinemia	2002
[Brochiectasis (in the adult)]. Praxis, 2007, Jun-13, Volume: 96, Issue:24 Topics: Adult; Aged; Aza Compounds; Bronchiectasis; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Immunization, Passive; Immunoglobulin M; Male; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Paraproteinemias; Quinolines; Rifabutin; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia	2007

Article

Year

BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.

Leukemia & lymphoma, 2002, Volume: 43, Issue:9

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Dexamethasone; Disease Progression; Female; Humans; Immunoglobulins; Male; Middle Aged; Multiple Myeloma; Thalidomide; Time Factors; Treatment Outcome; Waldenstrom Macroglobulinemia

2002

[Brochiectasis (in the adult)].

Praxis, 2007, Jun-13, Volume: 96, Issue:24

Topics: Adult; Aged; Aza Compounds; Bronchiectasis; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Immunization, Passive; Immunoglobulin M; Male; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Paraproteinemias; Quinolines; Rifabutin; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia

2007